Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 16, 2022

Efficacy of Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors

JAMA Oncology

 

Additional Info

JAMA Oncology
Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial
JAMA Oncol 2022 Nov 17;[EPub Ahead of Print], TA Yap, A Bardia, M Dvorkin, MD Galsky, JT Beck, DR Wise, O Karyakin, G Rubovszky, N Kislov, K Rohrberg, AA Joy, ML Telli, AM Schram, U Conte, C Chappey, R Stewart, D Stypinski, E Michelon, R Cesari, PA Konstantinopoulos

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading